The analysis of YY1 and BCL2L15 expression following CRC samples stratification based on cancer aggressiveness (i.e., metastasis vs. primary, mesenchymal vs. epithelial) was demonstrated to be a significant discriminator. Here, BCL2L15 is linked to colorectal carcinoma.